Join Now

Utah Life Sciences News & Events

Brandi Simpson

December 20, 2018

Navigen’s board of directors elected Brandi to be chief executive officer effective April 2014. She was Navigen’s first official employee, and from 2007 until her promotion to CEO she served as chief business officer of the company. Prior to joining Navigen, she held senior positions in business development, corporate strategy, and investor relations at NPS Pharmaceuticals, where she negotiated and closed multiple licensing transactions and led the company’s portfolio review and strategic decision-making processes. In her last year at NPS, she also served as the head of investor relations.

Prior to joining NPS, Brandi was director of business development at Emergen, a Utah genetics start-up. She was also a life sciences management consultant at Booz Allen & Hamilton, where she advised clients on a variety of business and strategic issues including mergers and acquisitions, post-merger integration and development of new business ventures. She began her career as an investment banking analyst at Merrill Lynch, where she worked on multiple public debt and equity financing transactions, structured financings, and mergers and acquisitions.

Brandi graduated summa cum laude from the University of Utah with an honors degree in Finance. She earned an MBA degree at Stanford University’s Graduate School of Business.